Cargando…

Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study

BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Jing, You, Chong, Lin, Qiushi, Hu, Taojun, Yu, Shicheng, Zhou, Xiao-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217033/
https://www.ncbi.nlm.nih.gov/pubmed/32511426
http://dx.doi.org/10.1101/2020.03.06.20032417
_version_ 1783532534382985216
author Qin, Jing
You, Chong
Lin, Qiushi
Hu, Taojun
Yu, Shicheng
Zhou, Xiao-Hua
author_facet Qin, Jing
You, Chong
Lin, Qiushi
Hu, Taojun
Yu, Shicheng
Zhou, Xiao-Hua
author_sort Qin, Jing
collection PubMed
description BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. METHODS: We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. FINDINGS: The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37–8·91), the mean is 8·62 days (95% CI: 8·02–9·28), the 90th percentile is 14·65 days (95% CI: 14·00–15·26), and the 99th percentile is 20·59 days (95% CI: 19·47, 21·62). Compared with results in other studies, the incubation period estimated in this study is longer. INTERPRETATION: Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods.
format Online
Article
Text
id pubmed-7217033
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-72170332020-06-07 Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study Qin, Jing You, Chong Lin, Qiushi Hu, Taojun Yu, Shicheng Zhou, Xiao-Hua medRxiv Article BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. METHODS: We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. FINDINGS: The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37–8·91), the mean is 8·62 days (95% CI: 8·02–9·28), the 90th percentile is 14·65 days (95% CI: 14·00–15·26), and the 99th percentile is 20·59 days (95% CI: 19·47, 21·62). Compared with results in other studies, the incubation period estimated in this study is longer. INTERPRETATION: Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods. Cold Spring Harbor Laboratory 2020-03-10 /pmc/articles/PMC7217033/ /pubmed/32511426 http://dx.doi.org/10.1101/2020.03.06.20032417 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/It is made available under a CC-BY-NC-ND 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Article
Qin, Jing
You, Chong
Lin, Qiushi
Hu, Taojun
Yu, Shicheng
Zhou, Xiao-Hua
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title_full Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title_fullStr Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title_full_unstemmed Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title_short Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
title_sort estimation of incubation period distribution of covid-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217033/
https://www.ncbi.nlm.nih.gov/pubmed/32511426
http://dx.doi.org/10.1101/2020.03.06.20032417
work_keys_str_mv AT qinjing estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy
AT youchong estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy
AT linqiushi estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy
AT hutaojun estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy
AT yushicheng estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy
AT zhouxiaohua estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy